James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

September Jobs Report: The Rest of the Story

The September jobs report initially spooked traders, and then encouraged them. Thing is, the jobs report numbers you hear the most are the ones that should concern you the most.

Twitter Stock Isn’t Any More Compelling With a Permanent Jack Dorsey

The steep plunge in the price of Twitter stock speaks volumes about what the market (rightfully) thinks of Jack Dorsey.

Why Dunkin Brands Group Inc (DNKN), Alcoa Inc (AA) and Twitter Inc (TWTR) Are 3 of Today’s Worst Stocks

Thursday's intraday bounceback effort didn't do Dunkin Brands Group (DNKN), Alcoa (AA) or Twitter (TWTR) a bit of good.

10 Biotech Stocks to Watch in Q4

Fans of biotech stocks have a lot to look forward to in the fourth quarter, with trial updates and a few potential drug approvals in the works.

Why Barracuda Networks Inc (CUDA), American Airlines Group Inc (AAL) and Gap Inc (GPS) Are 3 of Today’s Worst Stocks

Wednesday was on the disappointing side for owners of Barracuda Networks (CUDA), American Airlines (AAL) and Gap (GPS). Here's what investors need to know.